FindTrial
Sign In

Effectiveness of short chain fatty acid on Leukemia patients under induction Chemotherapy

Effectiveness of short-chain fatty acids in reducing the incidence of febrile neutropenia and bloodstream infections in pediatric acute lymphoblastic leukemia patients under induction chemotherapyâ??a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041018
Enrollment
56
Registered
2022-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D703- Neutropenia due to infection

Interventions

Intervention1: Butter: 10grams/day of Butter for 60 days Control Intervention1: Regular diet without Butter: Patients will be advised to take regular diet without adding butter

Sponsors

AIIMS Bhubaneshwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed Acute Lymphoblastic Leukaemia.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with other malignancies except ALL 2. Refusal to consent. 3. Symptoms of diarrhea, fever, documented microbial infection at presentation. 4. Hemodynamically unstable patients. 5.Allergic to milk and milk products

Design outcomes

Primary

MeasureTime frame
Reduce febrile neutropenia,blood stream infections,diarrhoeaTimepoint: 10 grams of a stool sample will be collected on baseline, day 1, day 7, day 35 and day 60—

Secondary

MeasureTime frame
Gut microbiome diversity in acute lymphoblastic leukemia patients and nutritional status of the patients during chemotherapy. Timepoint: 10 grams of a stool sample will be collected on baseline, day 1, day 7, day 35 and day 60—

Countries

India

Contacts

Public ContactDr Karthick velavan

AIIMS ,Bhubaneshwar

skarthickvelavan12@gmail.com8610075796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026